BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan

  The patent will allow for a method of isolating and differentiating a non-embryonic human brown adipose-derived stem cell into functional human brown adipocytes.

  October 17, 2017

   · 

  3 min read
• Business

  Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017

  The CEO and CFO will host a conference call to review the Company’s results at 8:00 a.m. Eastern Time the same day.

  October 17, 2017

   · 

  2 min read
• Business

  Cleveland Clinic Joins PierianDx’s Customer Network To Accelerate Precision Medicine

  PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patients.

  October 17, 2017

   · 

  1 min read
• Business

  Clinipace Worldwide Co-Founder and CEO Jeff Williams to Resign as CEO

  Will focus on board-level issues while Jason Monteleone takes over the reins.

  October 17, 2017

   · 

  2 min read
• Drug Development

  Immuron Highlights Market Opportunity Following Recent Studies on Antibiotic Correlation to C. Difficile Infections

  One study performed by the Minnesota Department of Health on antibiotic prescribing for dental procedures in community-associated clostridium difficile cases, which was presented at ID Week 2017.

  October 17, 2017

   · 

  6 min read
• Business

  Neximmune and the Leukemia & Lymphoma Society Enter Partnership for the Development of AIM ACT in AML Patients

  This will advance the Company’s novel cellular immunotherapy into Phase I clinical testing for patients with high risk AML who have relapsed after an allogeneic hematopoietic stem cell transplant.

  October 17, 2017

   · 

  3 min read
• Business

  Mauna Kea Technologies Appoints Olivier Regnard As Deputy CEO And Chief Financial Officer

  Mauna Kea Technologies announced the appointment of Olivier Regnard to the position of Deputy Chief Executive Officer and Chief Financial Officer, effective immediately.

  October 17, 2017

   · 

  4 min read
• Deals

  Neothetics and Evofem Biosciences Announce Merger Agreement to Create Women’s Health Company

  The merger will position the combined company with an opportunity to become a leading women’s health company that develops and commercializes novel products.

  October 17, 2017

   · 

  12 min read
• 

  Drug Development

  Aduro Biotech Announces Presentation of Phase I Data for LADD-based Immunotherapy at World Conference on Lung Cancer

  The Phase 1 first-in-human, open label dose-finding trial included nine patients with advanced stage relapsed or refractory non-small cell lung cancer.

  October 17, 2017

   · 

  5 min read
• Drug Development

  Immune Design Announces Positive FDA Feedback on Phase III Clinical Trial Design for CMB305 in Synovial Sarcoma Patients

  The company plans to initiate a pivotal Phase 3 trial to support a Biologics License Application for CMB305.

  October 17, 2017

   · 

  6 min read